The impact of early basal insulin treatment on inflammation and endothelial activation/damage related biomarkers in patients with type 2 diabetes mellitus

被引：0
|
作者：
Kesikli, S. A. [1 ]
Unluturk, U. [2 ]
Gunaydin, G. [1 ]
Ates, C. [2 ]
Guc, D. [1 ]
Uysal, A. R. [2 ]
Emral, R. [2 ]
机构：
[1] Hacettepe Univ, Inst Oncol, Ankara, Turkey
[2] Ankara Univ, Sch Med, TR-06100 Ankara, Turkey
来源：
IMMUNOLOGY | 2012年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [41] The role of basal insulin in the treatment of type 2 diabetes
    Antsiferov, M. B.
    Petraneva, E. V.
    DIABETES MELLITUS, 2006, 9 (04): : 19 - 22
  • [42] The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
    Fidan, Evren
    Ersoz, H. Onder
    Yilmaz, Mustafa
    Yilmaz, Hulya
    Kocak, Mustafa
    Karahan, Caner
    Erem, Cihangir
    ACTA DIABETOLOGICA, 2011, 48 (04) : 297 - 302
  • [43] COST-EFFECTIVENESS OF LIXISENATIDE COMBINED WITH BASAL INSULIN VERSUS INSULIN REGIMENS FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY BASAL INSULIN IN CHINA
    Men, P.
    Qu, S.
    Luo, W.
    Li, C.
    Zhai, S.
    VALUE IN HEALTH, 2019, 22 : S150 - S150
  • [44] Cost-effectiveness of lixisenatide combined with basal insulin versus insulin regimens for the treatment of patients in China with type 2 diabetes mellitus inadequately controlled by basal insulin
    Men, Peng
    Qu, Shuli
    Luo, Wenting
    Li, Chaoyun
    Zhai, Suodi
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [45] GLP-1-Agonists combined with Basal Insulin in the Treatment of Type 2 Diabetes mellitus
    Pavlicek, V.
    DIABETOLOGE, 2014, 10 (08): : 662 - 663
  • [46] Is postprandial platelet activation related to insulin rather than glucose levels in patients with type 2 diabetes mellitus?
    Spectre, G.
    Ostenson, C-G
    Li, N.
    Daleskog, M.
    Stalesen, R.
    Hjemdahl, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 344 - 344
  • [47] Basal Insulin Resistance and Secretion in Nigerians With Type 2 Diabetes Mellitus
    Oli, J. M.
    Adeyemo, A. A.
    Okafor, G. O.
    Ofoegbu, E. N.
    Onyenekwe, B.
    Chukwuka, C. J.
    Onwasigwe, C. N.
    Ufelle, S.
    Chen, G.
    Rotimi, C. N.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2009, 7 (06) : 595 - 599
  • [48] Lixisenatide added to basal insulin reduces glycaemic variability in patients with type 2 diabetes mellitus
    O'Neal, D.
    Umpierrez, G.
    DiGenio, A.
    Goldenberg, R.
    Hernandez-Triana, E.
    Lin, J.
    Park, C. -Y.
    Renard, E.
    Kovatchev, B.
    DIABETOLOGIA, 2014, 57 : S342 - S342
  • [49] Comparison of three titration algorithms for the initiation of basal insulin in patients with type 2 diabetes mellitus
    Aurand, L.
    Dailey, G.
    Stewart, J.
    Ameer, B.
    Zhou, R.
    DIABETOLOGIA, 2012, 55 : S383 - S384
  • [50] Lixisenatide plus basal insulin in patients with type 2 diabetes mellitus: a meta-analysis
    Charbonnel, Bernard
    Bertolini, Monica
    Tinahones, Francisco J.
    Puig Domingo, Manuel
    Davies, Melanie
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (06) : 880 - 886
12345